Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33826362

Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Jul 10
First author
Metzger ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Metzger ML
      type
      Author
    2. name
      Link MP
      type
      Author
    3. name
      Billett AL
      type
      Author
    4. name
      Flerlage J
      type
      Author
    5. name
      Lucas JT Jr
      type
      Author
    6. name
      Mandrell BN
      type
      Author
    7. name
      Ehrhardt MJ
      type
      Author
    8. name
      Bhakta N
      type
      Author
    9. name
      Yock TI
      type
      Author
    10. name
      Friedmann AM
      type
      Author
    11. name
      de Alarcon P
      type
      Author
    12. name
      Luna-Fineman S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Metzger ML
      type
      Author
    2. name
      Link MP
      type
      Author
    3. name
      Billett AL
      type
      Author
    4. name
      Flerlage J
      type
      Author
    5. name
      Lucas JT Jr
      type
      Author
    6. name
      Mandrell BN
      type
      Author
    7. name
      Ehrhardt MJ
      type
      Author
    8. name
      Bhakta N
      type
      Author
    9. name
      Yock TI
      type
      Author
    10. name
      Friedmann AM
      type
      Author
    11. name
      de Alarcon P
      type
      Author
    12. name
      Luna-Fineman S
      type
      Author
    bibliography ids
    1. nci-bib-5d2073d0416927ed1eed72f6
    book metadata
    content sha256
    924136c922b6388395f1fa574782c6bd231e94b1719b9b01f94e30cd93927cdb
    document type
    citation
    dois
    1. 10.1200/JCO.20.03286
    electronic publication date
    display
    2021 Apr 7
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33826362
    immutable id
    pubmed:33826362@924136c922b6388395f1fa574782c6bd231e94b1719b9b01f94e30cd93927cdb
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    20
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2276-2283
    volume
    39
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33826362
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      c7b3e08f097059118bba54ee68c0c490d6c53aa5cd8916285006b0f4acf48f0e
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Jul 10
      precision
      day
      year
      2021
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33826362/
      title
      Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation.

      Preserved source evidence · Not medical advice